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Abstract
Background and aims: Pulmonary arterial hypertension (PAH) sometimes accompanied 
patient with atrial septal defect (ASD). The 2015 European Society of Cardiology (ESC)/ 
European Respiratory Society (ERS) pulmonary hypertension (PH) guidelines recommend that 
risk assessment should be conducted using multiple parameters include a range of clinical, 
haemodinamic and exercise to evaluate disease progression and patient’s response to treatment. 
Right atrial pressure (RAP) is one of the haemodinamic parameter risk assessment in PAH. 
The aims of the present study were to investigated  whether risk assessment in PAH according 
to RAP  and correlation between mean pulmonary arterial pressure (mPAP) with RAP and in 
uncorrected ASD patients. 
Methods: A cross-sectional study was performed by analyzing right heart catheterization (RHC) 
data between July 2012 - Mei 2017 and a part of COHARD-PH (Congenital Heart Disease-
Pulmonary Hypertension) study from 299 adult patients with uncorrected ASD at Dr. Sardjito 
General Hospital. We used RAP as haemodinamic parameter of risk assessment in PAH. 
Right atrial pressure and mPAP were measured on RHC. Risk assessment in patients with 
PAH according to 2015 ESC PH guideline that divided RAP into 3 categories: low risk (RAP 
<8mmHg), intermediate risk (RAP 8-14mmHg) and high risk (RAP>14mmHg). The correlation 
between RAP and mPAP was assessed using non-parametric Spearman’s correlation analysis 
using SPSS 23. 
Results: Two hundred-ninety nine consecutive patients with ASD (257 females (86%) and 42 
males (14%), mean age 35.94 ± 12.81 years) underwent RHC and 209 (69.8%) patients have 
PAH. The mean RAP and mPAP were 13.09 ± 5.93mmHg and 38.78 ± 20.67mmHg respectively. 
Eighteen (8.6%), 102 (48.8%) and 89 (42.6%) patients were in the low, intermediate and high risk 
assessment categories in PAH according to RAP respectively. Mean pulmonary arterial pressure 
has signifi cant correlation with RAP (r = 0.340, P =<0.0001) in uncorrected ASD patients. 
Conclusions: In our study, mostly ASD patients were in intermediate risk followed by high 
risk and low risk assessment in PAH according to RAP. Mean pulmonary arterial pressure has 
moderate signifi cant correlation with RAP in uncorrected ASD patients.
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